来自官方财务报表的收入、利润与现金流历史。
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V.
| 利润表 | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|---|
| 总收入 | $8.3B | $8.3B | $8.3B | $8.2B | $8.1B | $8.2B | $7.3B |
| 毛利 | $4.5B | $4.5B | $4.6B | $4.7B | $4.7B | $4.9B | $4.3B |
| 毛利率% | 54.7% | 53.5% | 55.6% | 57.2% | 57.8% | 60.2% | 59.3% |
| 营业利润（EBIT） | $2.1B | $2.2B | $1.0B | $1.7B | $1.7B | $1.9B | $1.4B |
| 营业利润率% | 25.0% | 26.2% | 12.6% | 20.6% | 20.8% | 23.0% | 19.6% |
| 净利 | $1.4B | $1.6B | $479M | $1.3B | $1.3B | $1.5B | $1.1B |
| 净利润率 % | 17.3% | 18.7% | 5.8% | 16.4% | 16.5% | 17.9% | 15.6% |
| EBITDA | — | $2.5B | $1.5B | $2.2B | $2.3B | $2.5B | $2.0B |
| 每股收益（EPS） | $8.18 | $8.88 | $2.76 | $7.79 | $7.79 | $8.47 | $6.60 |
| 已发行股数 (M) | — | 175M | 174M | 173M | 172M | 172M | 172M |
来源：公司公开报告（SEC）。在依赖任何数字前请核对 SEC EDGAR。
资产负债表、现金流、季度数据与完整财务比率见 SOLV 交互式查看器。 /companies/us/SOLV
本网站信息仅用于教育与参考，不构成投资建议。不发布目标价或买卖建议。
About TickerBase · Data methodology & sources · Privacy · Terms